Patents by Inventor Michael McFarlane

Michael McFarlane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240135787
    Abstract: A display includes two-integrated cameras. A first camera is situated in a top right corner of a front display surface of the display and a second camera is situated in a top left corner of the front display surface. The display is connected to a transaction terminal with the first camera focused on a bagging area associated with the transaction terminal and with the second camera focused on a staging area associated with the transaction terminal. Each camera captures images of items and the item images are streamed over a high-speed display port directly to the transaction terminal. The transaction terminal performs item recognition, item tracking, and auditing on the items based the item images during transaction processing at the transaction terminal.
    Type: Application
    Filed: December 27, 2023
    Publication date: April 25, 2024
    Inventors: Steven James Birnie, Ian McFarlane Denny, Michael Peter Gillies
  • Patent number: 11919813
    Abstract: A lime-based cement extender composition, and associated systems and methods are disclosed herein. In some embodiments, the lime-based cement extender composition includes 5-20% by weight lime particles, 40-50% by weight limestone particles, and 40-50% by weight pozzolan particles. Additionally or alternatively, the lime-based cement extender composition can comprise a calcium oxide concentration of 45-65%, a magnesium oxide concentration of 0.5-2%, an iron oxide concentration of 0.5-2.0%, an aluminum oxide concentration of 2-8%, a silicon dioxide concentration of 20-40%, a potassium oxide concentration of 20,000-30,000 ppm, and a sodium oxide concentration of 10,000-20,000 ppm. In some embodiments, the lime-based cement extender composition, or product, is combined with cement to produce a cement blend for use in the mining industry as mine backfill.
    Type: Grant
    Filed: December 22, 2022
    Date of Patent: March 5, 2024
    Assignee: Graymont Western Canada Inc.
    Inventors: Nikolas Andrei Romaniuk, Michael John Tate, Narain Hariharan, Jared Ira Leikam, Katherine Hyman, Lucas McFarlane, Joseph Lewis
  • Patent number: 11922783
    Abstract: A display includes two-integrated cameras. A first camera is situated in a top right corner of a front display surface of the display and a second camera is situated in a top left corner of the front display surface. The display is connected to a transaction terminal with the first camera focused on a bagging area associated with the transaction terminal and with the second camera focused on a staging area associated with the transaction terminal. Each camera captures images of items and the item images are streamed over a high-speed display port directly to the transaction terminal. The transaction terminal performs item recognition, item tracking, and auditing on the items based the item images during transaction processing at the transaction terminal.
    Type: Grant
    Filed: September 23, 2022
    Date of Patent: March 5, 2024
    Assignee: NCR Corporation
    Inventors: Steven James Birnie, Ian McFarlane Denny, Michael Peter Gillies
  • Publication number: 20240072212
    Abstract: Solid-state lighting devices including light-emitting diodes (LEDs) and more particularly sealing structures for LED packages are disclosed. Sealing structures include multiple seals within an LED package that provide a multiple barrier structure for enhanced protection from elemental ingress from a surrounding environment. Certain seals may be provided as bonding materials between cover structures and submounts of LED packages, thereby enclosing LED chips. Additional seals may be provided as coatings on surfaces of LED chips and/or submounts that are between cover structures and LED chips. Sealing structures may include multiple levels of hermetic seals with LED packages.
    Type: Application
    Filed: August 24, 2022
    Publication date: February 29, 2024
    Inventors: Tucker McFarlane, Robert Wilcox, David Suich, Thomas Celano, Michael Check, Colin Blakely
  • Patent number: 10335693
    Abstract: A universal controller holster for holding one- or two-lobed controllers on the person of a user, such as game controllers is disclosed. The universal controller holster is adjustable and designed to hold on the person of a user most controllers that are commercially available. The universal controller holster comprises two collars connected together by an arm and further to a spine having an angled tooth at one end. The spine is adjustably fastenable to a mount having a plurality of detents to which the angled tooth of the spine can be attached, thus adjusting the height of the mount to accommodate the size of various controllers. The universal controller holster further comprises a clip that can be used to attach the holster to a user such as the waist band of slacks or a belt, or can be used to attach to other items such as a purse or any other item. The universal controller holster allows for the user to hold the controller hands-free while moving and changing locations.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: July 2, 2019
    Assignee: Integr8ted Minds Inc.
    Inventors: Michael A. McFarlane, Jr., Jamarcus J. Watkins
  • Patent number: 9097588
    Abstract: A UV radiation (UVR) response indicator comprises a first UVB and/or UVA radiation sensitive material which has been modified so as to display an altered characteristic in a delayed manner in response to UVB and/or UVA radiation exposure. The UV indicator is capable of displaying exposure to increased UV radiation over a period of time. The present invention also relates to a method of displaying a relative amount of exposure to UVR by a UV indicator over a period of time. The invention is particularly useful in detecting the level of exposure to sunlight or sunbed radiation.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: August 4, 2015
    Assignee: Intellego Technologies AB
    Inventors: Andrew Mills, Michael McFarlane, Kate McDiarmid, Pauline Grosshans
  • Patent number: 8754240
    Abstract: The present invention relates to a chemical process for the manufacture of a compound of Formula II
    Type: Grant
    Filed: November 17, 2010
    Date of Patent: June 17, 2014
    Assignee: AstraZeneca AB
    Inventors: Euan Alexander Arnott, John Crosby, Mathew Charles Evans, James Gair Ford, Martin Francis Jones, Kevin William Leslie, Ian Michael McFarlane, George Joseph Sependa
  • Publication number: 20130053729
    Abstract: Embodiments relate generally to urine diversion devices for positioning, in use, at least partly within a toilet bowl. The device in some embodiments comprises a body defining a basin and having a collection side and diverting means to divert urine received in the basin toward the collection side; foldable wings coupled to opposed sides of the body and positionable to overlie at least part of respective opposed sides of a toilet seat; and a cradle to hold a urine receptacle and extending from the collection side of the body, the cradle arranged to support the urine receptacle to receive urine diverted toward the collection side.
    Type: Application
    Filed: May 11, 2011
    Publication date: February 28, 2013
    Applicant: FWEE PTY LTD
    Inventors: Darinka Stevic-Wages, Brendan McKeegan, Phillip Michael McFarlane, Paul Charlwood, Luca Abate
  • Publication number: 20120137958
    Abstract: A UV radiation (UVR) response indicator comprises a first UVB and/or UVA radiation sensitive material which has been modified so as to display an altered characteristic in a delayed manner in response to UVB and/or UVA radiation exposure. The UV indicator is capable of displaying exposure to increased UV radiation over a period of time. The present invention also relates to a method of displaying a relative amount of exposure to UVR by a UV indicator over a period of time. The invention is particularly useful in detecting the level of exposure to sunlight or sunbed radiation.
    Type: Application
    Filed: December 18, 2009
    Publication date: June 7, 2012
    Inventors: Andrew Mills, Michael McFarlane, Kate McDiarmid, Pauline Grosshans
  • Publication number: 20110257395
    Abstract: The present invention relates to chemical processes for the manufacture of certain quinazoline derivatives, or pharmaceutically acceptable salts thereof. The invention also relates to processes for the manufacture of certain intermediates useful in the manufacture of the quinazoline derivatives and to processes for the manufacture of the quinazoline derivatives utilising said intermediates. In particular, the present invention relates to chemical processes and intermediates useful in the manufacture of the compound 4-(4-fluoro-2-methylindol-5-yloxy)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline.
    Type: Application
    Filed: November 17, 2010
    Publication date: October 20, 2011
    Applicant: AstraZeneca AB
    Inventors: Euan Alexander Arnott, John Crosby, Matthew Charles Evans, James Gair Ford, Martin Francis Jones, Kevin William Leslie, Ian Michael McFarlane, George Joseph Sependa
  • Publication number: 20110253722
    Abstract: A method for waterproofing a mobile device and a waterproofed mobile device are provided. The method is designed to keep the internal components from elements, such as water, the can damage the mobile device. The method adds a protective coating of a lightweight sealable, heat shrinkable plastic to the internal components of the mobile device and heat shrinks the ends of the of the a lightweight sealable, heat shrinkable plastic together to waterproof the internal components.
    Type: Application
    Filed: April 20, 2010
    Publication date: October 20, 2011
    Applicant: TOMORROW'S INNOVATIONS
    Inventors: Cleveland Morrow, Michael McFarlane
  • Patent number: 7851623
    Abstract: The present invention relates to chemical processes for the manufacture of certain quinazoline derivatives, or pharmaceutically acceptable salts thereof. The invention also relates to processes for the manufacture of certain intermediates useful in the manufacture of the quinazoline derivatives and to processes for the manufacture of the quinazoline derivatives utilising said intermediates. In particular, the present invention relates to chemical processes and intermediates useful in the manufacture of the compound 4-[(4-fluoro-2-methy-1-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline starting from a compound of Formula IX: wherein R4 is a protecting group; or an intermediate there between, using process steps, reagents and conditions as described.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: December 14, 2010
    Assignee: AstraZeneca AB
    Inventors: Euan Alexander Arnott, John Crosby, Matthew Charles Evans, James Gair Ford, Martin Francis Jones, Kevin William Leslie, Ian Michael McFarlane, George Joseph Sependa
  • Publication number: 20080221322
    Abstract: The present invention relates to chemical processes for the manufacture of certain quinazoline derivatives, or pharmaceutically acceptable salts thereof. The invention also relates to processes for the manufacture of certain intermediates useful in the manufacture of the quinazoline derivatives and to processes for the manufacture of the quinazoline derivatives utilising said intermediates. In particular, the present invention relates to chemical processes and intermediates useful in the manufacture of the compound 4-(4-fluoro-2-methylindol-5-yloxy)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline.
    Type: Application
    Filed: October 31, 2007
    Publication date: September 11, 2008
    Applicant: AstraZeneca AB
    Inventors: Euan Alexander Arnott, John Crosby, Mathew Charles Evans, James Gair Ford, Martin Francis Jones, Kevin William Leslie, Ian Michael McFarlane, George Joseph Sependa
  • Patent number: 6255326
    Abstract: This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase.
    Type: Grant
    Filed: January 27, 1999
    Date of Patent: July 3, 2001
    Assignee: Aventis Pharma Limited
    Inventors: Michael John Ashton, David Charles Cook, Garry Fenton, Susan Jacqueline Hills, Ian Michael McFarlane, Andrew David Morley, Malcolm Norman Palfreyman, Andrew James Ratcliffe, Brian William Sharp, Sukanthini Thurairatnam, Bernard Yvon Jack Vacher, Nigel Vicker
  • Patent number: 6096768
    Abstract: This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase.
    Type: Grant
    Filed: April 29, 1999
    Date of Patent: August 1, 2000
    Assignee: Rhone-Poulenc Rorer Limited
    Inventors: Michael John Ashton, David Charles Cook, Garry Fenton, Susan Jacqueline Hills, Ian Michael McFarlane, Andrew David Morley, Malcolm Norman Palfreyman, Andrew James Ratcliffe, Brian William Sharp, Sukanthini Thurairatnam, Bernard Yvon Jack Vacher, Nigel Vicker
  • Patent number: 5935978
    Abstract: This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase.
    Type: Grant
    Filed: July 28, 1993
    Date of Patent: August 10, 1999
    Assignee: Rhone-Poulenc Rorer Limited
    Inventors: Garry Fenton, Andrew David Morley, Malcolm Norman Palfreyman, Andrew James Ratcliffe, Brian William Sharp, Sukanthini Thurairatnam, Bernard Yvon Jack Vacher, Michael John Ashton, David Charles Cook, Susan Jacqueline Hills, Ian Michael McFarlane, Nigel Vicker
  • Patent number: D815829
    Type: Grant
    Filed: January 10, 2017
    Date of Patent: April 24, 2018
    Assignee: Integr8ted Minds Inc.
    Inventors: Michael A. McFarlane, Jr., Jamarcus J. Watkins